Breaking News Instant updates and real-time market news.

BANR

Banner Corp.

$57.59

0.08 (0.14%)

, CATY

Cathay General

$36.53

0.02 (0.05%)

04:55
03/14/19
03/14
04:55
03/14/19
04:55

Stephens to hold a field trip

West Coast Bank Field Trip travels throughout the West Coast to meet with several regional banks will start in Portland, Oregon and end in San Francisco on March 12-14.

BANR

Banner Corp.

$57.59

0.08 (0.14%)

CATY

Cathay General

$36.53

0.02 (0.05%)

EWBC

East West Bancorp

$52.71

0.85 (1.64%)

FFWM

First Foundation

$14.55

0.16 (1.11%)

FIBK

First Interstate

$41.99

0.26 (0.62%)

FRC

First Republic

$102.81

0.37 (0.36%)

GBCI

Glacier Bancorp

$41.02

0.19 (0.47%)

HFWA

Heritage Financial

$31.40

0.14 (0.45%)

PACW

PacWest Bancorp

$39.48

0.41 (1.05%)

PPBI

Pacific Premier

$28.22

0.27 (0.97%)

SIVB

SVB Financial

$243.98

3.01 (1.25%)

TCBK

TriCo Bancshares

$39.97

0.33 (0.83%)

UMPQ

Umpqua Holdings

$17.59

-0.06 (-0.34%)

  • 30

    Apr

  • 14

    May

  • 21

    May

  • 22

    May

BANR Banner Corp.
$57.59

0.08 (0.14%)

10/26/18
FIGP
10/26/18
UPGRADE
FIGP
Outperform
Banner Corp. upgraded to Outperform from Market Perform at Fig Partners
CATY Cathay General
$36.53

0.02 (0.05%)

05/02/18
WEDB
05/02/18
UPGRADE
WEDB
Outperform
Cathay General upgraded to Outperform from Neutral at Wedbush
05/02/18
05/02/18
UPGRADE
Target $49

Outperform
Cathay General upgraded to Outperform at Wedbush
As previously reported, Wedbush analyst David Chiaverini upgraded Cathay General to Outperform from Neutral and adding it to the Best Ideas List owing to its steady growth in loans and deposits, above-average asset sensitivity, potential for buybacks below $40 per share, yet-to-be realized cost-saves, and an attractive valuation as it trades at a two multiple discount to both its historical multiple and relative to peers. The analyst also raised his price target on the shares to $49 from $47.
04/19/18
DADA
04/19/18
NO CHANGE
Target $43.5
DADA
Neutral
Cathay General price target lowered to $43.50 from $48 at DA Davidson
DA Davidson analyst Gary Tenner lowered his price target on Cathay General to $43.50 after the bank's Q4 results. Tenner notes that while the earnings were in line and net interest margins were better than expected, loan growth was "moderate" and credit provision was negative for the 25th consecutive quarter. The analyst keeps his Neutral rating on Cathay General.
EWBC East West Bancorp
$52.71

0.85 (1.64%)

10/01/18
BMOC
10/01/18
UPGRADE
Target $73
BMOC
Outperform
East West Bancorp upgraded to Outperform at BMO Capital on pullback
As reported earlier, BMO Capital analyst Lana Chan upgraded East West Bancorp to Outperform from Market Perform and kept her price target at $73. The analyst says the recent stock price pullback, driven by declining net interest margin expansion and concerns over the impact of China trade tariffs, is an opportunity for investors to buy into a longer-term story of "demographic growth in the Chinese-American niche and cross-border opportunities". Chan believes the outlook for East West Bancorp's "solid earnings growth" is favorable and sees the bank on track to meet its 10% loan growth target in 2018.
10/22/18
DADA
10/22/18
UPGRADE
DADA
Buy
East West Bancorp upgraded to Buy from Neutral at DA Davidson
11/27/18
DADA
11/27/18
UPGRADE
DADA
Buy
East West Bancorp upgraded to Buy from Neutral at DA Davidson
02/12/19
PIPR
02/12/19
NO CHANGE
Target $76
PIPR
Overweight
East West shares 'too cheap' given 'greenfield opportunity,' says Piper Jaffray
After meeting with management, Piper Jaffray analyst Matthew Clark is "feeling better" about East West Bancorp's growth prospects and net interest margin outlook. A "greenfield opportunity" exists on the cross border front with relatively new product capabilities and a disciplined focus on industry verticals that support a double digit growth outlook, Clark tells investors in a research note. He believes East West shares are "too cheap" and keeps an Overweight rating on the name with a $76 price target.
FFWM First Foundation
$14.55

0.16 (1.11%)

07/31/18
SDLR
07/31/18
DOWNGRADE
SDLR
Hold
First Foundation downgraded to Hold from Buy at Sandler O'Neill
FIBK First Interstate
$41.99

0.26 (0.62%)

10/16/18
BARD
10/16/18
INITIATION
Target $52
BARD
Outperform
First Interstate initiated with an Outperform at Baird
Baird analyst Bryce Rowe initiated First Interstate with an Outperform rating, citing its valuable core franchise, its acquisition strategy, its ongoing infrastructure initiatives, and balance sheet growth. Rowe has a $52 price target on First Interstate shares.
01/14/19
SPHN
01/14/19
INITIATION
Target $45
SPHN
Overweight
First Interstate initiated with an Overweight at Stephens
Stephens analyst Gordon McGuire initiated First Interstate with an Overweight rating and a price target of $45. The analyst says that while the banking industry is heading for headwinds amid "looking credit concerns", he believes that investors will reward banks "with strong franchise value, conservative execution, and tail winds to improve profitability. McGuire adds that First Interstate BancSystem is trading at a discount relative to its close competitors in spite of its premium valuation relative to the industry, with an added upside catalyst coming from the eventual removal of its dual class voting structure.
04/26/18
FIGP
04/26/18
UPGRADE
FIGP
Outperform
First Interstate upgraded to Outperform from Market Perform at Fig Partners
FRC First Republic
$102.81

0.37 (0.36%)

01/16/19
WELS
01/16/19
NO CHANGE
Target $110
WELS
Outperform
First Republic price target raised to $110 from $100 at Wells Fargo
Wells Fargo analyst Jared Shaw raised his price target for First Republic to $110 from $100 after the bank posted a "strong quarter" marked by record loan production and a better net interest margin. As one of the biggest consensus shorts heading into earnings, the strong balance sheet performance and better NIM result resulted in a 10% rebound in shares, he notes. Shaw continues to view First Republic as one of the best positioned banks, as it remains one of his top picks for 2019. He reiterates an Outperform rating on the shares.
01/10/19
BOFA
01/10/19
DOWNGRADE
BOFA
Neutral
First Republic downgraded to Neutral on valuation, fee outlook at BofA/Merrill
As previously reported, BofA/Merrill downgraded First Republic to Neutral from Buy and cut its price target to $94. Analyst Erika Najarian said First Republic's best in class revenue growth is already reflected in valuation and the flat yield curve poses risk to net interest margin. Najarian also expects challenges to investment advisory fees due to difficult markets and efficiency to be down.
01/10/19
BOFA
01/10/19
DOWNGRADE
BOFA
Neutral
First Republic downgraded to Neutral from Buy at BofA/Merrill
03/01/19
ATLE
03/01/19
DOWNGRADE
ATLE
Neutral
First Republic downgraded to Neutral from Overweight at Atlantic Equities
GBCI Glacier Bancorp
$41.02

0.19 (0.47%)

01/14/19
SPHN
01/14/19
INITIATION
Target $42
SPHN
Equal Weight
Glacier Bancorp initiated with an Equal Weight at Stephens
Stephens analyst Gordon McGuire initiated Glacier Bancorp with an Equal Weight rating and $42 price target, stating that he believes the stock's premium valuation is deserved and can be sustained, but he also sees 2020 EPS headwinds as he expects "a sizeable step-up" in provisioning levels due to CECL implementation.
HFWA Heritage Financial
$31.40

0.14 (0.45%)

03/06/19
SPHN
03/06/19
INITIATION
SPHN
Equal Weight
Heritage Financial initiated with an Equal Weight at Stephens
03/07/19
SPHN
03/07/19
INITIATION
Target $36
SPHN
Equal Weight
Stephens starts Heritage Financial at Equal Weight on valuation
As previously reported, Stephens analyst Gordon McGuire initiated Heritage Financial with an Equal Weight rating, calling it one of, if not the best small-cap pure plays to own for exposure to the Pacific Northwest's metro economies. However, while he expects the stock to maintain its current premium valuation, McGuire would seek a more attractive entry point for nearer-term outperformance. He set a $36 price target on Heritage Financial shares.
05/02/18
PIPR
05/02/18
UPGRADE
Target $35
PIPR
Overweight
Heritage Financial upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Matthew Clark upgraded Heritage Financial to Overweight and raised his price target for the shares to $35 from $34. The analyst raised his 2019 estimates to reflect a "much stronger" net interest margin outlook following the company's Q1 results. He recommends taking advantage of the recent weakness in Heritage shares.
07/26/18
KBWI
07/26/18
DOWNGRADE
Target $38
KBWI
Market Perform
Heritage Financial downgraded to Market Perform at Keefe Bruyette
Keefe Bruyette analyst Jacquelynne Bohlen downgraded Heritage Financial to Market Perform from Outperform while raising her price target for the shares to $38 from $36. The analyst cites the recent share outperformance and "meaningful increase" in Heritage's "valuation premium gap" for the downgrade. She remains positive on the company's strategy.
PACW PacWest Bancorp
$39.48

0.41 (1.05%)

03/06/19
PIPR
03/06/19
NO CHANGE
PIPR
Banc of California a sale candidate, just not today, says Piper Jaffray
Banc of California (BANC) will ultimately end up in the hands of someone else, just not today, Piper Jaffray analyst Matthew Clark tells investors in a research note. The analyst does not believe the hiring of Jared Wolff, with an M&A background at PacWest Bancorp (PACW), as CEO, and the involvement of long-time bank investor Rich Lashley on the board is coincidental. Clark says the "unexpected decision" by CEO Doug Bowers to resign and not see his three-year plan come to fruition reinforces his view. He likes the risk/reward on Banc of California shares and keeps an Overweight rating on the name with a $20 price target.
01/14/19
JMPS
01/14/19
NO CHANGE
Target $44
JMPS
Outperform
PacWest Bancorp price target lowered to $44 from $59 at JMP Securities
JMP Securities analyst Christopher York lowered his price target on PacWest Bancorp shares to $44 from $59 after the bank announced the termination of the deal to acquire El Dorado Savings Bank as it did not receive approval by El Dorado shareholders. The fact that PacWest did not look to adjust the terms of the deal, either before or after the vote, indicates in his view that the company is a disciplined acquirer and is unlikely to revisit a merger with closely-held El Dorado in the future, York stated. He maintains an Outperform rating on PacWest shares.
02/24/19
KBWI
02/24/19
DOWNGRADE
Target $45
KBWI
Market Perform
PacWest Bancorp downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Christopher McGratty downgraded PacWest Bancorp to Market Perform and lowered his price target for the shares to $45 from $50. The shares are approaching fair value, McGratty tells investors in a research note.
01/22/19
BMOC
01/22/19
NO CHANGE
Target $38
BMOC
Market Perform
PacWest Bancorp price target raised to $38 from $34 at BMO Capital
BMO Capital analyst Lana Chan raised her price target on PacWest Bancorp to $38 after its Q4 earnings beat driven by a more favorable tax rate. The analyst notes that the company's 2018 was also supported by the strong loan growth that gives it good momentum to hit mid-single digit rate of increase this year, but warns that net interest margin compression could also pose a challenge. Chan expects PacWest Bancorp to resume its stock buybacks after its cancelled El Dorado acquisition.
PPBI Pacific Premier
$28.22

0.27 (0.97%)

SIVB SVB Financial
$243.98

3.01 (1.25%)

01/28/19
RHCO
01/28/19
NO CHANGE
Target $280
RHCO
Buy
SVB Financial price target raised to $280 from $260 at SunTrust
SunTrust analyst Jennifer Demba raised her price target on SVB Financial to $280 and kept her Buy rating after its Q4 earnings beat, saying the results were driven by "healthy" growth in loans, net interest margins, and core fees, with expenses also coming in flat. The analyst adds that the company saw improved loan loss provisioning, while the overall valuations in regional banks have also turned higher over the last few weeks.
01/03/19
PIPR
01/03/19
NO CHANGE
Target $285
PIPR
Overweight
SVB Financial price target lowered to $285 from $352 at Piper Jaffray
Piper Jaffray analyst Brett Rabatin lowered his price target for SVB Financial Group to $285 citing higher risk to the company's "rapid" earnings growth due to slower growth and less net interest margin upside potential. The analyst, however, thinks SVB should trade for a premium to peers on forward earnings despite his belief that consensus estimates are too high. He keeps an Overweight rating on the shares.
12/27/18
12/27/18
NO CHANGE

Stephens to keep GrubHub, RealPage, Vulcan Materials on 2019 Best Ideas list
Stephens said that it plans to publish a complete updated 2019 Best Ideas list on January 2, but in anticipation it shared the names that are being dropped and the three stocks that will remain on the list. The holdovers are GrubHub (GRUB), RealPage (RP) and Vulcan Materials (VMC). The stocks being removed include Boston Scientific (BSX), Brookdale Senior Living (BKD), Conn's (CONN), CoStar Group (CSGP), Curo Group (CURO), FedEx (FDX), First Financial Bancorp (FFBC), Graphic Packaging (GPK), Hub Group (HUBG), Keane Group (FRAC), KeyCorp (KEY), LKQ Corp. (LKQ), Myriad Genetics (MYGN), SVB Financial (SIVB), Triumph Bancorp (TBK), TrueCar (TRUE) and Union Bankshares (UBSH).
01/25/19
RBCM
01/25/19
NO CHANGE
Target $300
RBCM
Outperform
SVB Financial price target lowered to $300 from $320 at RBC Capital
RBC Capital analyst Jon Arfstrom lowered his price target on SVB Financial to $300 after its Q4 results, saying that while its earnings were better than expected, they also included 25c in gains from securities, warrants, derivatives, and forex revaluations. The analyst is keeping his Outperform rating on SVB Financial given its favorable outlook and strong client activity, with average loans rising over 4% sequentially on strength in PE/VC capital call lines, life sciences, and private bank activity.
TCBK TriCo Bancshares
$39.97

0.33 (0.83%)

05/11/18
SPHN
05/11/18
INITIATION
Target $43
SPHN
Overweight
Stephens sees 'scarcity value' in TriCo Bancshares, starts at Overweight
As previously reported, Stephens analyst Tyler Stafford started TriCo Bancshares with an Overweight rating and $43 price target, stating that he believes a high degree of scarcity value in California could make its franchise attractive to larger acquirers seeking a greater presence in the state. He views a potential sale of the company over the next few years as a possible catalyst.
05/11/18
SPHN
05/11/18
INITIATION
SPHN
Overweight
TriCo Bancshares initiated with an Overweight at Stephens
UMPQ Umpqua Holdings
$17.59

-0.06 (-0.34%)

11/21/18
PIPR
11/21/18
UPGRADE
Target $20
PIPR
Neutral
Umpqua Holdings upgraded to Neutral from Underweight at Piper Jaffray
Piper Jaffray analyst Matthew Clark upgraded Umpqua Holdings to Neutral with an unchanged price target of $20. The analyst sees fewer earnings headwinds and notes the stock is down 9% year-to-date. Sentiment is "washed out" and the shares now offer a 4.4% dividend yield and trade at a modest discount to peers, Clark tells investors in a research note.
05/02/18
05/02/18
DOWNGRADE
Target $25

Neutral
Umpqua Holdings downgraded to Neutral at Wedbush
As previously reported, Wedbush analyst David Chiaverini downgraded Umpqua Holdings to Neutral from Outperform, with a $25 price target, on valuation as the stock has been the third-best performing mid-cap in his coverage on a year-to-date basis.
05/02/18
WEDB
05/02/18
DOWNGRADE
WEDB
Neutral
Umpqua Holdings downgraded to Neutral from Outperform at Wedbush

TODAY'S FREE FLY STORIES

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

, INCY

Incyte

$77.76

1.385 (1.81%)

04:55
06/16/19
06/16
04:55
06/16/19
04:55
Conference/Events
European Hematology Association to hold a conference »

24th EHA Congress 2019…

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

INCY

Incyte

$77.76

1.385 (1.81%)

ARQL

ArQule

$8.17

1.88 (29.89%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

ALXN

Alexion

$117.94

0.65 (0.55%)

AGIO

Agios Pharmaceuticals

$47.97

-1.78 (-3.58%)

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

BLUE

Bluebird Bio

$117.57

-6.33 (-5.11%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

NSTG

NanoString

$25.96

0.45 (1.76%)

KPTI

Karyopharm

$5.71

-0.04 (-0.70%)

JAZZ

Jazz Pharmaceuticals

$130.43

0.28 (0.22%)

GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

GILD

Gilead

$66.38

-0.62 (-0.93%)

DSNKY

Daiichi Sankyo

$0.00

(0.00%)

PFE

Pfizer

$42.75

0.24 (0.56%)

PTLA

Portola Pharmaceuticals

$25.78

-0.31 (-1.19%)

QGEN

Qiagen

$39.52

-0.07 (-0.18%)

RHHBY

Roche

$0.00

(0.00%)

RIGL

Rigel Pharmaceuticals

$2.06

-0.06 (-2.83%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

SGEN

Seattle Genetics

$68.67

-0.33 (-0.48%)

STML

Stemline

$14.20

0.12 (0.85%)

VSTM

Verastem

$1.39

0.125 (9.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 23

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 06

    Jul

  • 25

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 02

    Sep

  • 03

    Sep

  • 16

    Sep

  • 04

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

, GRUB

GrubHub

$70.15

-2.76 (-3.79%)

13:28
06/15/19
06/15
13:28
06/15/19
13:28
Periodicals
Amazon exit gives GrubHub stock boost, Barron's says »

Amazon (AMZN) is…

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 10

    Jul

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

, CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

13:20
06/15/19
06/15
13:20
06/15/19
13:20
Periodicals
McKesson, Cardinal Health looking like bargains, Barron's says »

Investors have halved the…

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

MCK

McKesson

$133.19

-1.7 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

RTN

Raytheon

$177.38

0.195 (0.11%)

, UTX

United Technologies

$125.30

0.45 (0.36%)

13:09
06/15/19
06/15
13:09
06/15/19
13:09
Periodicals
United Technologies, Raytheon stocks looking cheap, Barron's says »

Shares of United…

RTN

Raytheon

$177.38

0.195 (0.11%)

UTX

United Technologies

$125.30

0.45 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

, AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

13:04
06/15/19
06/15
13:04
06/15/19
13:04
Periodicals
Food fight extending well beyond restaurant delivery, Barron's says »

Amazon (AMZN) is quitting…

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 10

    Jul

GOOGL

Alphabet Class A

$1,086.36

-4.65 (-0.43%)

, GOOG

Alphabet

$1,085.56

-3.52 (-0.32%)

12:59
06/15/19
06/15
12:59
06/15/19
12:59
Periodicals
Facebook, JPMorgan chiefs among Best CEOs of 2019, Barron's says »

Separated into three…

GOOGL

Alphabet Class A

$1,086.36

-4.65 (-0.43%)

GOOG

Alphabet

$1,085.56

-3.52 (-0.32%)

FB

Facebook

$181.35

3.88 (2.19%)

MCD

McDonald's

$205.33

0.85 (0.42%)

JPM

JPMorgan

$109.84

0.26 (0.24%)

BAC

Bank of America

$28.03

0.09 (0.32%)

BLK

BlackRock

$446.96

-1.29 (-0.29%)

BX

Blackstone

$44.13

0.17 (0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 09

    Jul

  • 10

    Jul

  • 16

    Jul

  • 17

    Jul

  • 06

    Aug

  • 27

    Oct

AVGO

Broadcom

$265.99

-15.96 (-5.66%)

, AAPL

Apple

$192.84

-1.93 (-0.99%)

07:17
06/15/19
06/15
07:17
06/15/19
07:17
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AVGO

Broadcom

$265.99

-15.96 (-5.66%)

AAPL

Apple

$192.84

-1.93 (-0.99%)

HNHPF

Hon Hai Precision

$0.00

(0.00%)

UTX

United Technologies

$125.30

0.45 (0.36%)

RTN

Raytheon

$177.38

0.195 (0.11%)

CGC

Canopy Growth

$41.15

-0.64 (-1.53%)

TLRY

Tilray

$38.96

-1.78 (-4.37%)

APHA

Aphria

$6.80

-0.15 (-2.16%)

ACB

Aurora Cannabis

$7.56

(0.00%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

CRON

Cronos Group

$15.43

-0.92 (-5.63%)

CANN

General Cannabis

$0.00

(0.00%)

IGC

India Globalization Capital

$1.28

0.4201 (48.85%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

ZYNE

Zynerba

$13.03

-0.54 (-3.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

  • 18

    Jun

  • 19

    Jun

  • 21

    Jun

  • 25

    Jun

  • 09

    Jul

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

, ABMD

Abiomed

$250.96

-4.58 (-1.79%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
International League of Dermatological Societies to hold a conference »

24th World Congress of…

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

ABMD

Abiomed

$250.96

-4.58 (-1.79%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

LLY

Eli Lilly

$111.74

-0.06 (-0.05%)

JNJ

Johnson & Johnson

$140.08

-0.63 (-0.45%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

PFE

Pfizer

$42.75

0.24 (0.56%)

PG

Procter & Gamble

$111.20

0.28 (0.25%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

UL

Unilever; also tag UN

$62.61

-0.07 (-0.11%)

UN

Unilever; also tag UL

$61.30

-0.13 (-0.21%)

INCY

Incyte

$77.76

1.385 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 26

    Jun

  • 27

    Jun

  • 16

    Jul

  • 25

    Jul

  • 30

    Jul

  • 28

    Aug

  • 03

    Sep

  • 16

    Sep

  • 13

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

, GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
European Congress of Rheumatology to hold a conference »

EULAR 2019 will be held…

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

PFE

Pfizer

$42.75

0.24 (0.56%)

LLY

Eli Lilly

$111.74

-0.06 (-0.05%)

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

RHHBY

Roche

$0.00

(0.00%)

BIIB

Biogen

$227.67

-3.57 (-1.54%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

GILD

Gilead

$66.38

-0.62 (-0.93%)

REGN

Regeneron

$305.19

-2.235 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 25

    Jul

  • 30

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 02

    Sep

  • 03

    Sep

  • 16

    Sep

  • 04

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

ABT

Abbott

$82.25

-0.03 (-0.04%)

, AMGN

Amgen

$176.09

-0.74 (-0.42%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
Society for Vascular Surgery to hold annual meeting »

SVS Annual Meeting 2019…

ABT

Abbott

$82.25

-0.03 (-0.04%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

BSX

Boston Scientific

$40.41

-0.26 (-0.64%)

PFE

Pfizer

$42.75

0.24 (0.56%)

CRY

CryoLife

$29.13

-0.13 (-0.44%)

EW

Edwards Lifesciences

$184.00

-0.63 (-0.34%)

ELGX

Endologix

$7.61

0.2 (2.70%)

IAC

IAC

$228.41

-2.63 (-1.14%)

HCA

HCA Healthcare

$126.64

-0.76 (-0.60%)

LMAT

LeMaitre

$26.04

-0.44 (-1.66%)

ORGO

Organogenesis

$7.39

0.02 (0.27%)

OSIR

Osiris

$0.00

(0.00%)

PEN

Penumbra

$166.75

2.93 (1.79%)

SWAV

ShockWave Medical

$58.27

-0.99 (-1.67%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 26

    Jun

  • 09

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 16

    Sep

  • 25

    Sep

  • 13

    Nov

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

, INCY

Incyte

$77.76

1.385 (1.81%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
European Hematology Association to hold a conference »

24th EHA Congress 2019…

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

INCY

Incyte

$77.76

1.385 (1.81%)

ARQL

ArQule

$8.17

1.88 (29.89%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

ALXN

Alexion

$117.94

0.65 (0.55%)

AGIO

Agios Pharmaceuticals

$47.97

-1.78 (-3.58%)

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

BLUE

Bluebird Bio

$117.57

-6.33 (-5.11%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

NSTG

NanoString

$25.96

0.45 (1.76%)

KPTI

Karyopharm

$5.71

-0.04 (-0.70%)

JAZZ

Jazz Pharmaceuticals

$130.43

0.28 (0.22%)

GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

GILD

Gilead

$66.38

-0.62 (-0.93%)

DSNKY

Daiichi Sankyo

$0.00

(0.00%)

PFE

Pfizer

$42.75

0.24 (0.56%)

PTLA

Portola Pharmaceuticals

$25.78

-0.31 (-1.19%)

QGEN

Qiagen

$39.52

-0.07 (-0.18%)

RHHBY

Roche

$0.00

(0.00%)

RIGL

Rigel Pharmaceuticals

$2.06

-0.06 (-2.83%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

SGEN

Seattle Genetics

$68.67

-0.33 (-0.48%)

STML

Stemline

$14.20

0.12 (0.85%)

VSTM

Verastem

$1.39

0.125 (9.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jun

  • 17

    Jun

  • 18

    Jun

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 23

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 06

    Jul

  • 25

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 02

    Sep

  • 03

    Sep

  • 16

    Sep

  • 04

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

CNC

Centene

$53.52

-0.26 (-0.48%)

, WCG

WellCare

$287.16

0.145 (0.05%)

18:45
06/14/19
06/14
18:45
06/14/19
18:45
Hot Stocks
Centene CEO: Medicare for all will not work »

In an interview on…

CNC

Centene

$53.52

-0.26 (-0.48%)

WCG

WellCare

$287.16

0.145 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

HMC

Honda

$25.34

-0.405 (-1.57%)

18:24
06/14/19
06/14
18:24
06/14/19
18:24
Hot Stocks
Honda recalls all 2016-2019 model year Pioneer vehicles »

Honda is conducting a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$111.28

1.42 (1.29%)

18:22
06/14/19
06/14
18:22
06/14/19
18:22
Hot Stocks
RH CEO: We think our stock is massively undervalued »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

Dish

$37.54

-0.35 (-0.92%)

, S

Sprint

$7.01

0.2 (2.94%)

18:08
06/14/19
06/14
18:08
06/14/19
18:08
Periodicals
Dish leads bidding for Sprint, T-Mobile assets, WSJ reports »

Dish Network (DISH) is…

DISH

Dish

$37.54

-0.35 (-0.92%)

S

Sprint

$7.01

0.2 (2.94%)

TMUS

T-Mobile

$74.90

0.44 (0.59%)

CHTR

Charter

$392.20

2.76 (0.71%)

ATUS

Altice USA

$23.82

0.15 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$32.69

-0.39 (-1.18%)

17:31
06/14/19
06/14
17:31
06/14/19
17:31
Periodicals
American Air asks court to end 'devastating' work slowdown, Bloomberg says »

American Airlines urged a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROLL

RBC Bearings

$150.43

-3.38 (-2.20%)

17:16
06/14/19
06/14
17:16
06/14/19
17:16
Hot Stocks
RBC Bearings CEO sells over 5,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNW

FTE Networks

$1.25

(0.00%)

17:14
06/14/19
06/14
17:14
06/14/19
17:14
Hot Stocks
FTE Networks granted financial viability exception by NYSE regulation »

FTE Networks announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$347.19

-1.54 (-0.44%)

17:14
06/14/19
06/14
17:14
06/14/19
17:14
Hot Stocks
Boeing awarded Air Force contract modification, increases ceiling by $6.53B »

Boeing has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 09

    Jul

MDR

McDermott

$7.60

-0.12 (-1.55%)

17:11
06/14/19
06/14
17:11
06/14/19
17:11
Hot Stocks
Chatterjee Fund Management reports 5.6% passive stake in McDermott »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZZA

Papa John's

$50.74

0.28 (0.55%)

17:09
06/14/19
06/14
17:09
06/14/19
17:09
Hot Stocks
Papa John's dismisses KPMG as auditors, hires Ernst & Young »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 20

    Jun

  • 20

    Jun

  • 13

    Nov

EPZM

Epizyme

$11.62

-0.36 (-3.01%)

16:55
06/14/19
06/14
16:55
06/14/19
16:55
Conference/Events
Epizyme to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

CACI

CACI

$202.80

-1.205 (-0.59%)

16:54
06/14/19
06/14
16:54
06/14/19
16:54
Conference/Events
CACI to hold a conference call »

Management holds a fiscal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

HCR

Hi-Crush Inc.

$2.84

0.115 (4.22%)

16:53
06/14/19
06/14
16:53
06/14/19
16:53
Syndicate
Hi-Crush Inc files $1B mixed securities shelf »

The company also files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHIP

Seanergy Marine

$0.63

-0.0381 (-5.70%)

16:51
06/14/19
06/14
16:51
06/14/19
16:51
Earnings
Seanergy Marine reports Q1 EPS ($3.23), two estimates ($2.85) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.